Home
Conditions
Narcotic-Related Disorders

Clinical trial condition

Narcotic-Related Disorders

Explore clinical trials studying Narcotic-Related Disorders. Study availability and eligibility vary by location and protocol.

1,300 public trials 199 recruiting studies

Refine in advanced search Browse all conditions

Narcotic-Related Disorders trial results

Completed

ALK21-013: Efficacy and Safety of Medisorb® Naltrexone (VIVITROL®) in Adults With Opioid Dependence

NCT00678418

Conditions: Behavior, Behavior, Addictive, Chemically-Induced Disorders, +8 more
Locations: Ethics Committee within the Federal Authority for Healthcare and Social Development Regulation Moscow, Russia

View Trial Details

Completed

Activity Monitoring Assessment of Opiate Withdrawal - 4

NCT00000335

Conditions: Chemically-Induced Disorders, Mental Disorders, Narcotic-Related Disorders, +3 more
Locations: Washington DC VA Washington D.C., District of Columbia, United States

View Trial Details

Completed

Pharmacokinetics, Safety, and Tolerability of Depot Buprenorphine at Three Different Molecular Weights in Treatment-Seeking Subjects With Opioid Use Disorder

NCT02559973

Conditions: Chemically-Induced Disorders, Mental Disorders, Narcotic-Related Disorders, +3 more
Locations: Vince & Associates Clinical Research Overland Park, Kansas, United States

View Trial Details

Completed

Comparison of Buprenorphine and Methadone - 3

NCT00000334

Conditions: Chemically-Induced Disorders, Mental Disorders, Narcotic-Related Disorders, +3 more
Locations: Washington DC VA Washington D.C., District of Columbia, United States

View Trial Details

Completed

Transfer of Subjects From Subutex/Suboxone to RBP-6300

NCT01582347

Conditions: Chemically-Induced Disorders, Mental Disorders, Narcotic-Related Disorders, +3 more
Locations: Prof. Dr. Fleischhacker Austria

Dr. Lindenbauer Linz, Austria

Prof. Dr. Wurst Salzburg, Austria

Prof. Wolzt Vienna, Austria

View all 15 locations

View Trial Details

Completed

Trial of Buprenorphine/Naloxone for Opiate Dependence - 2

NCT00000353

Conditions: Chemically-Induced Disorders, Mental Disorders, Narcotic-Related Disorders, +4 more
Locations: University of Pennsylvania Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Buprenorphine and Naloxone for the Treatment of Opiate Dependence - 1

NCT00015171

Conditions: Chemically-Induced Disorders, Heroin Dependence, Mental Disorders, +4 more
Locations: New York MDRU New York, United States

View Trial Details

Completed

Buprenorphine/Naloxone for Opiate-Dependence Treatment - 1

NCT00015028

Conditions: Chemically-Induced Disorders, Mental Disorders, Narcotic-Related Disorders, +4 more
Locations: Cincinnati MDRU Cincinnati, Ohio, United States

View Trial Details

Completed

RESPECT-PLUS: Services for Infants With Prenatal Opiate Exposure

NCT02334111

Conditions: Chemically-Induced Disorders, Child Abuse, Child Development, +9 more
Locations: Boston Medical Center Boston, Massachusetts, United States

View Trial Details

Completed

Bridging Active Heroin Users to Hepatitis C Treatment Using Buprenorphine - 1

NCT00249574

Conditions: Blood-Borne Infections, Chemically-Induced Disorders, Communicable Diseases, +14 more
Locations: O.A.S.I.S. Oakland, California, United States

View Trial Details

Narcotic-Related Disorders

Narcotic-Related Disorders trial results

Related conditions